All updates
All updates
today 22Nature评分4040 中文产业新闻Chinese source评分6161 Forbion完成26亿美元新基金募资，礼来参投
中文产业新闻Chinese source评分4242 荷兰新锐RougeTx完成5800万美元A轮融资，开发HHT疾病修饰疗法RTX-001
中文产业新闻精选Chinese source评分6363 AiCuris在TANDEM会议公布pritelivir治疗免疫低下患者难治性HSV感染的关键3期数据
中文产业新闻精选Chinese source评分7979 Vaxcyte 31价肺炎球菌结合疫苗 VAX-31 三期 OPUS-1 头对头辉瑞与默沙东达全部主要终点
中文产业新闻Chinese source评分6262 Glycomine旗下GLM101获FDA突破性疗法认定，用于治疗PMM2-CDG
中文产业新闻Chinese source评分5757 天津医科大学郝继辉团队在Cell提出'功能性抗原屏蔽'解释ADC治疗性别差异与耐药
中文产业新闻Chinese source评分2121 2026年诺贝尔化学奖正式揭晓
中文产业新闻精选Chinese source评分7272 中南大学湘雅医院团队多组学研究在《Science》发表，明确肠道菌群-关节保护通路
中文产业新闻Chinese source评分2828 GLP-1再陪跑诺奖：2026年生理学或医学奖授予光遗传学三位奠基者
中文产业新闻Chinese source评分5555 诺贝尔化学奖授予不对称有机合成中非线性效应与自催化研究
中文产业新闻Chinese source评分6363 艾力斯伏美替尼FURVENT III期未达PFS主要终点
中文产业新闻Chinese source评分6464 伏美替尼全球III期FURVENT研究未达PFS主要终点，艾力斯出海路径承压
中文产业新闻Chinese source评分5252 Ultragenyx以2.1亿美元出售罕见儿科疾病PRV
中文产业新闻Chinese source评分6969 2026年诺贝尔化学奖授予Kagan与硖合宪三，表彰不对称合成中非线性效应与自催化
中文产业新闻Chinese source评分4747 评2026年诺贝尔化学奖：卡甘与硖合宪三因不对称合成非线性效应与自催化获奖
中文产业新闻Chinese source评分5555 诺奖加冕手性化学：10个手性药，一部制药史
临床试验登记评分2323 TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma
临床试验登记评分2121 Phase 1b Study of TX002100 in Participants With Hematologic Support-Dependent Hereditary Hemorrhagic Telangiectasia (HHT)
临床试验登记评分3333 Biomarker-guided Reduction of Immunosuppression in Liver Transplant Recipients (BRITRE)
临床试验登记评分3232 Immunogenicity and Safety of Two Respiratory Syncytial Virus Vaccine Strategies in Lung and Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Phase 2 Trial
临床试验登记评分2222 Phase 1/2 Multicenter, Open-label, Dose-escalation Study of IDP- 121 in Patients With Platinum-resistant Small Cell Lung Cancer (MYCrocytic)
临床试验登记评分3333 An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer.
临床试验登记评分3333 A Phase II Study of Anlotinib + PD-1 Inhibitor vs. PD-1 Inhibitor Maintenance After First-Line Chemoimmunotherapy in Advanced ESCC (Esophageal Squamous Cell Carcinoma)
临床试验登记评分3333 A Trial of AGMB-447 in Participants With Idiopathic Pulmonary Fibrosis
临床试验登记评分2222 US/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III Triple Negative Breast Cancer Receiving Neoadjuvant Immunotherapy and Chemotherapy
临床试验登记评分2626 RYZ711 Diagnostic Platform Study
临床试验登记评分3232 Neoadjuvant RP2 + Nivolumab in Patients With Melanoma
临床试验登记评分2121 A Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma With FGFR2 Fusion or Rearrangements After at Least 1 Prior Line of Systemic Therapy
临床试验登记评分3030 DOR/ISL in Pediatric Participants With HIV-1, <18 Years of Age and ≥ 35 kg
临床试验登记评分3535 Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC
临床试验登记评分3333 Vitamin E Versus Silymarin in Non Diabetic MASLD Patients
临床试验登记评分2828 Safety and Efficacy Study in Adults With Advanced Solid Tumors Receiving REGN13089-M404-M2980, an Antibody-drug Conjugate That Targets MET Protein on Tumors
FDA Drugs精选评分8080 FDA approves tucatinib with trastuzumab and pertuzumab for the maintenance treatment of HER2-positive breast cancer
FDA Drugs精选评分5555 Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosing
顶刊论文（社媒热度）精选评分6969 RNA structure modulates Cas13 activity and enables mismatch detection.
Science Translational Medicine评分2020 Turning the tables: Repurposing neuroplasticity to defeat cancer
Science Translational Medicine评分1212 Erratum for the Research Article “Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design”
Science Translational Medicine评分6161 Use of split intein and myotropic AAV vectors enables effective preclinical gene therapy for dysferlinopathy
Science Translational Medicine评分5858 A multiomic atlas reveals distinct immune landscapes in preterm and term chronic placental inflammation